News In the press

One Virtual Biotech's Strategy

Small biotechs in the biosimilar arena have been catching the eye; in fact, a very noteworthy development is the rise of small biosimilar players around the world. If they don’t already have a product on the market right now, they’re announcing successful Phase 1 clinical trial results for second-wave products.

One of these up-and-coming companies is BiosanaPharma, a virtual biotech out of the Netherlands.